Document:

Exhibit
10.14

 

HELIX
TCS, INC.

5300
DTC Parkway, STE 220

Greenwood
Village, CO 80111

 

TERM
SHEET AND SUMMARY OF THE OFFERING

(for
Accredited Investors Only)

$___________
of Convertible Unsecured Promissory Notes

 

The
following summary of Terms is intended for quick reference only and is not intended to be complete. This Term Sheet describes
in more detail aspects of the investment that are material to prospective investors in our company. They must be read in their
entirety by prospective investors.

 

Statements
contained in this Term Sheet as to the content of any other agreement or document are not necessarily complete, and each such
statement is deemed to be qualified in all respects by the provisions of those agreements and documents, copies of which are available
for examination by prospective investors upon request.

 

	Issuer:	 	Helix
    TCS, Inc. is a Delaware corporation, with our principal office at 5300 DTC Parkway, STE 220, Greenwood Village, CO 80111.
    Unless the context otherwise requires, all references to “we,” “us,” “our company,” “Helix
    TCS” or “Company” refer collectively to Helix TCS, Inc.
	 	 	 
	Business:	 	Helix
    TCS is involved in building and providing security, logistics, and information exchange platforms in the cannabis industry
    space. The Company seeks to expand its operations with the funds raised herein. 
	 	 	 
	Securities
    Offered:	 	We
    are offering $_________ in Unsecured Convertible Promissory Notes, convertible in increments to shares of common stock, at
    a 20% discount to the five day average closing price at time of conversion.  The Notes will have a minimum conversion
    price of $.20  The notes bear interest @ 7% per annum due date December 31, 2017.
	 	 	 
	No
    Minimum Offering:	 	There
    is no minimum amount of the Offering. We may immediately begin to utilize proceeds upon receipt of any subscriptions.
	 	 	 
	Maximum
    Offering:	 	$___________
    consisting of Unsecured Convertible Promissory Notes.
	 	 	 
	Payment
    for Subscriptions:	 	Subscriptions
    for Notes in the Offering must be accompanied by payment in full of the subscription amount. Payment may be in the form of
    a check or wire transfer. 

 

    	Term Sheet (Helix TCS)	1

     

    

 

	Use
    of Proceeds:	 	We
    intend to use the proceeds of the Offering toward expanding operations, research and product development in the cannabis information
    related products business, general and administrative, and working capital expenses over the next six months.
	 	 	 
	Future
    Capital Raises:	 	We
    anticipate that we will require substantial additional capital in excess of the maximum amount of this Offering in order to
    continue to pursue our business plan successfully.
	 	 	 
	Trading
    Status:	 	Our
    Notes are not publicly traded in any venue, nor quoted, but our common stock is trading on the OTC Pink Sheets under the symbol
    "HLIX". 
	 	 	 
	Securities
    Law Restrictions On Transfer of Securities Acquired:	 	The
    notes, and underlying common stock if converted, are restricted securities under the U.S. federal and state securities laws.
    They may not be sold, transferred, hypothecated or otherwise disposed of in the absence of an effective registration statement
    or an exemption from registration acceptable to the Company.
	 	 	 
	Liquidity:	 	Investors
    in this Offering may not be able to sell the notes, as there is no market for the notes, or any converted shares of our common
    stock may be sold in the open market. There is a limited trading market on the Pink Sheets for our common stock, quoted as
    "HLIX".
	 	 	 
	Interest
    Rate:	 	The
    Notes shall bear interest @ 7% per annum payable annually in cash
	 	 	 
	Debt
                                         currently outstanding:

         
	 	$100,000,
    except current payables
	 	 	 
	Conversion Rights into
    shares of Common Stock at a 20% discount to market on the notice of conversion date:	 	The
                                         Convertible Promissory Noted are convertible into Common Stock of the Company. The conversion
                                         rights shall be adjusted in the event of any merger, consolidation, reorganization recapitalization,
                                         reverse, or forward split under the terms hereof.

 

    	Term Sheet (Helix TCS)	2

     

    

 

	 	 	Elective
                                         Conversion: The principal balance of the Note shall be convertible at the election
                                         of the Holder of Note, in whole or in part, at any time and from time to time, upon written
                                         notice, into the Company’s common stock at a 20% discount to the average closing
                                         price for the previous 5 trading days, subject to a minimum conversion price of $.20
                                         per share.

         

        Mandatory
        Conversion: The principal balance of the Note shall also automatically convert into shares of Common Stock upon the
        completion of the following event (the “Conversion Event”):

         

        (a)
        the Company shall have an effective S-1 registration with the Securities and Exchange Commission (“SEC”).

         

        Upon
        the occurrence of the Conversion Event, the Note shall automatically convert, without further notice to or action by any
        person, into an equivalent number of shares of the Company’s common stock at a 20% discount to the average market
        closing price for the previous 5 trading days preceding the effective date of the S-1 registration. The date of conversion
        of the Note shall be the date on which the mandatory conversion event above has been accomplished.

         

        A
        Mandatory Conversion shall take not take place unless the underlying shares of common stock of the Company are covered
        by an effective registration statement filed by the Company with the SEC, or are exempt from registration under the Act.

         

        The
        accrued interest of the Convertible Promissory Note may be converted into the Company’s Common Stock at noteholder
        option, if registered common shares are available.

	 	 	 
	Redemption	 	If,
                                         on the 2nd Anniversary of each holder's Closing Date (as defined below), any of their
                                         Notes have not been converted into common stock, then the Company shall redeem the Note
                                         in one of two methods, as elected by the Holder of such Note in their sole discretion:

 

1.
The Company shall redeem the Note by paying Holder the cash amount of $2.00 per every one dollar of unconverted Note held, plus
any accrued and unpaid dividends.

 

    	Term Sheet (Helix TCS)	3

     

    

 

	 	 	

        In
        the event that the Company is unable to effect such cash redemption as elected by a Holder, then the Company shall issue
        to the Note Holder (“Holder”) on the date of redemption a senior secured note obligating the Company to pay
        the redemption amount to Holder on terms not to exceed twelve (12) months at an interest rate of fourteen percent (14%)
        per annum.

         

        or

         

        2.
        The Company shall issue shares of common stock (which must be covered by an effective registration statement filed by
        the Company with the SEC) to the Holder. The number of shares of common stock for each dollar of unconverted Note shall
        be calculated as follows:

         

        (a)
        If the average quoted closing bid price, if any, for the preceding 10 trading days with an average trading volume of at
        least $20,000 a day is $1.00 or more, then the Company shall issue 2 shares of common stock for each $1.00 of unpaid Note
        principal.

         

        In
        the event of this election, any accrued and unpaid dividends shall be paid in cash by the Company without any 2x liquidation
        provisions just simple interest accrued but also may be paid in common shares under Rule 144 provisions.

         

        The
        Company shall notify Holder of the Redemption Date at least 90 days prior to the Redemption Date. The Holder shall make
        such election at least 30 days prior to the Redemption Date. If the Holder fails to make any election, then the Company
        may make such election at the Company’s discretion.

         

	Mandatory
    Redemption in Event of Sale:	 	In
                                         the event of a sale of all of the capital stock of the Company after its pending merger,
                                         or substantially all of the assets of the Company, the Company shall redeem any unconverted
                                         Note principal on the closing date of the sale at a rate of $1.50 per dollar of unpaid
                                         principal in cash (or the equivalent in securities, as referenced below), plus payment
                                         in cash or shares of any accrued and unpaid dividends. However, if the sale price (or
                                         participation in the sale) for the fully diluted common stock of the Company is more
                                         than $1.00 per share of common stock, then any unconverted Note balance shall convert
                                         at a 2:1 ratio into common stock immediately prior to the closing of the sale for a 2x
                                         Liquidation Preference for each Note Holder.

 

    	Term Sheet (Helix TCS)	4

     

    

 

	 	 	If
the sale price is a combination of cash and securities of the purchaser, then the Holders of Note shall be paid as if converted
@ $1.00 in the same ratio of cash to securities as the other Holders of common stock for a 2x Liquidation Preference. If the securities
of the purchaser are subject to any restriction (i.e. unregistered or lock-up), the sale transaction shall be subject to a shareholder
vote, with Note Holder having a vote equal to the number of shares of common as if converted at $1.00 for a 2x Liquidation Preference.

         

	Assets:	 	Security
    service business and contracts.
	 	 	 
	Risk
    Factors:	 	This
    Offering and the contemplated investment involve significant risks, including our lack of operating history and the risk that
    we will not be successful in obtaining sufficient funding to pursue our business plan or begin revenues to be able to provide
    an adequate return to investors.  This should be considered a high risk, as a startup company.
	 	 	 
	Sale
    and Private Placement of Securities:	 	This
    Offering will be made in reliance upon the Rule 506 of Regulation D exemption from the registration requirements of federal
    and state securities laws. This Offering will terminate upon the earlier to occur of (i) May 31, 2016 or such other date as
    the Company in its sole discretion may select, or (ii) receipt and acceptance by the Company of subscriptions for the sale
    of all the notes offered in this Offering (the “Closing Date”). All subscriptions must satisfy the requirements
    set forth in the Subscription Agreement enclosed with this Memorandum.
	 	 	 
	Investor
    Suitability:	 	The
    notes are being offered to a limited number of prospective investors who are “accredited investors” (as defined
    in Rule 501 under the Securities Act of 1933, as amended (the “Securities Act”)) pursuant to a private placement
    being made in reliance upon two or more exemptions from the registration requirements of federal and state securities laws
    and will not be registered under federal securities laws or under the securities laws of any state. Neither the SEC nor the
    regulatory authority of any state has endorsed the merits of this Offering or passed upon the accuracy or adequacy of this
    Memorandum. Each purchaser will be required in connection with the purchase of the notes to make representations confirming
    that the purchaser is eligible as a prospective investor and that the purchaser is purchasing the securities for the purchaser’s
    own account and not with a view to resale or distribution of the securities.
	 	 	 
	No
    Registration Rights:	 	This
    Company will not register any promissory notes, or shares, of Common Stock in connection with this Offering. All Notes and
    Shares will be subject to the Securities Act of 1933 and Rule 144.
	 	 	 
	Capital
    Structure:	 	The
    Company has 200,000,000 common shares and 20,000,000 Preferred authorized and 25,873,211 common shares issued and outstanding
    as of the date hereof.  Approximately 86% of such outstanding shares are owned by our management and principal shareholder,
    and which owns 1,000,000 shares of Class A Preferred Super Majority Voting, convertible to 60% of common shares at all times.

 

    	Term Sheet (Helix TCS)	5

     

    

 

ACCREDITED
INVESTOR

SUBSCRIPTION
AGREEMENT AND REPRESENTATIONS

 

Helix
TCS, Inc.

 

Gentlemen:

 

I,
the undersigned, understand that Helix TCS Inc., a Delaware Corporation (the “Company”) is offering an Unsecured Convertible
Promissory Note ("Note", or "Notes"), convertible to common shares at time of conversion as set forth in the
form of the Note (“Common Share”) (“the Securities”).

 

I
hereby offer to purchase a Unsecured Convertible Promissory Note in the amount of $________ and upon acceptance by you, agree
to become a Note holder of the Company and to contribute to the Company as set forth herein. In order to induce the Company to
accept my offer, I advise you as follows:

 

(1)
Receipt of copies of the Term Sheet and such other documents as I have requested. I hereby acknowledge that I have received
the Term Sheet and Business Plan documents (as may be supplemented from time to time) relating to the Company.

 

(2)
Availability of Information. I hereby acknowledge that the Company has made available to me the opportunity to ask questions
of, and receive answers from the Company and any other person or entity acting on its behalf, concerning the contents of the Term
Sheet and Business Plan and the information contained in the corporate documents and to obtain any additional information, to
the extent the Company possesses such information or can acquire it without unreasonable effort or expense, necessary to verify
the accuracy of the information provided by the Company and any other person or entity acting on its behalf.

 

(3)
Representations and Warranties. I represent and warrant to the Company (and understand that it is relying upon the accuracy
and completeness of such representations and warranties in connection with the availability of an exemption for the offer and
sale of the securities from the registration requirements of applicable federal and state securities laws) that:

 

(A)
RESTRICTED SECURITIES.

 

(1)
I understand that the notes, shares, and warrants (collectively "the Securities") have not been registered under
the Securities Act of 1933, as amended (The Act), or any state securities laws.

 

(2)
I understand that if my subscription offer is accepted and the Securities are sold to me, I cannot sell or otherwise dispose of
the Securities unless the securities are registered under the Act or the state securities laws or exemptions therefrom are available
(and consequently, that I must bear the economic risk of the investment for an indefinite period of time):

 

(3)
I understand that the Company has no obligation now or at any time to register the Securities under the Act or the State securities
laws or obtain exemptions therefrom.

 

(4)
I understand that the Company will restrict the transfer of the Securities in accordance with the foregoing representations.

 

(B)
LEGEND.

 

I
agree that any certificate representing the Securities will contain and be endorsed with the following, or a substantially equivalent,
LEGEND:

 

“This
security has been acquired pursuant to an investment representation by the holder and shall not be sold, pledged, hypothecated
or donated, or otherwise transferred except upon the issuance to Company of a favorable opinion by its counsel and the submission
to the Company of other evidence satisfactory to and as required by counsel to the Company; that any such transfer will not violate
the Securities Act of 1933, as amended, and applicable state securities laws.

 

    	Term Sheet (Helix TCS)	6

     

    

 

(C)
AGE: CITIZENSHIP.

 

I
am at least twenty-two years old and a citizen of ____________________.

 

(D)
ACCURACY OF INFORMATION.

 

All
information which I have provided to the Company concerning my financial position and knowledge of financial and business matters
is correct and complete as of the date set forth at the end hereof, and if there should be any material change in such information
prior to acceptance of this subscription offer by the Company, I will immediately provide the Company with such information.

 

(5)
OFFERING ACCEPTANCE PROCEDURE.

 

I
understand that this subscription offer is subject to each of the following terms and conditions:

 

(a)
The Company may reject this subscription offer for any reason, and this subscription offer shall become binding upon the Company
only when accepted, in writing, by the Company.

 

(b)
This subscription offer may not be withdrawn by me.

 

(6)
SUITABILITY. I hereby warrant and represent:

 

(a)
That I can afford a complete loss of the investment and can afford to hold the securities being purchased hereunder for an indefinite
period of time;

 

(b)
That I consider this investment a suitable investment and;

 

(c)
That I have had prior experience in financial matters and investments.

 

(7)
RESTRICTIONS.

 

This
subscription is personal to the investor whose name and address appear below. It may not be sold, transferred, assigned or otherwise
disposed of to any other person, natural or artificial.

 

(8)
CONDITIONS.

 

This
subscription shall become binding upon the Company and me only when accepted, in writing, by the issuer.

 

(9)
REPRESENTATIONS.

 

(a)
I have been furnished and have carefully read the Company Private Placement Memorandum (“PPM”) attached as exhibits
thereto, including the Subscription Agreement. I am aware that:

 

(1)
There are substantial risks incident to the ownership of Securities in the Company, and such investment is speculative and involves
a high degree of risk of loss by me of my entire investment in the Company;

 

(2)
No federal or state agency has passed upon the Securities or made any finding or determination concerning the fairness of this
investment;

 

    	Term Sheet (Helix TCS)	7

     

    

 

(b)
I acknowledge that I have been advised to consult my own attorney concerning the investment.

 

(c)
I acknowledge that the investment in the Company is an illiquid investment. In particular, I recognize that:

 

(1)
Due to restrictions described below, the lack of any market existing or to exist for these Securities, in the event I should attempt
to sell my securities in the Company, my investment will be highly illiquid and, probably must be held indefinitely.

 

(2)
I must bear the economic risk of investment in the Securities for an indefinite period of time, since the Securities have not
been registered under the Securities Act of 1933, as amended. Therefore, the Securities cannot be offered, sold, transferred,
pledged, or hypothecated to any person unless either they are subsequently registered under said Act or an exemption from such
registration is available and the favorable opinion of counsel for the Company to that effect is obtained, which is not anticipated.

 

(3)
My right to transfer my Securities will also be restricted as provided in this Subscription Agreement.

 

(d)
I represent and warrant to the Company that:

 

(1)
I have carefully reviewed and understand the risks of, and other considerations relating to, a purchase of Securities, including
the risks set forth in this Agreement.

 

(2)
I and my investment advisors, if any, have been furnished all materials relating to the Company and its proposed activities, the
offering of Securities, or anything set forth in the Tern Sheet and Business Plan, which they have requested and have been afforded
the opportunity to obtain any additional information necessary to verify the accuracy of any representations or information set
forth in the documents;

 

(3)
The Company has answered all inquiries that I and my investment advisors, if any, have put to it concerning the Company and its
proposed activities and the offering and sale of the Securities;

 

(4)
Neither I nor my investment advisors, if any, have been furnished any offering literature other than the Term Sheet and SEC filings
and I and my investment advisors, if any, have relied only on the information contained in such filings and the information, as
described in subparagraphs (b) and (c) above, furnished or made available to them by the Company;

 

(5)
I am acquiring the shares for which I hereby subscribe for my own account, as principal, for investment purposes only and not
with a view to the resale or distribution of all or any part of such Securities, and that I have no present intention, agreement
or arrangement to divide my participation with others or to resell, transfer or otherwise dispose of all or any part of the Securities
subscribed for unless and until I determine, at some future date, that changed circumstances, not in contemplation at the time
of this purchase, makes such disposition advisable;

 

(6)
I, the undersigned, if on behalf of a corporation, partnership, trust, or other form of business entity, affirm that: it is authorized
and otherwise duly qualified to purchase and hold Securities in the Company; recognize that the information under the caption
as set forth in (a) above related to investments by an individual and does not address the federal income tax consequences of
an investment by any of the aforementioned entities and have obtained such additional tax advice that I have deemed necessary;
such entity has its principal place of business as set forth below; and such entity has not been formed for the specific purpose
of acquiring Securities in the Company.

 

(7)
I have adequate means of providing for my current needs and personal contingencies and have no need for liquidity in this investment;
and

 

    	Term Sheet (Helix TCS)	8

     

    

 

(e)
I hereby adopt, accept, and agree to be bound by all the terms and conditions of this Agreement, and by all of the terms and conditions
of the Articles of Incorporation, and amendments thereto, and By-Laws. Upon acceptance of this Subscription Agreement by the Company,
I shall become a shareholder and warrant holder for all purposes, and the securities subscribed shall be issued.

 

(f)
The Subscription, upon acceptance by the Company, shall be binding upon the heirs, executors, administrators, successors, and
assigns of mine.

 

(g)
I hereby represent and warrant that:

 

(1)
I have either a net worth (exclusive of home, home furnishings, and automobiles) of at least ten times the amount of the investment.
If a corporation, it is on a consolidated basis according to its most recent financial statement, within the above standards,
and if a partnership, each partner is within the above standards.

 

(h)
I further hereby represent that either:

 

(1)
I have such knowledge and experience in business and financial matters that I am capable of evaluating the Company and proposed
activities thereof, the risks and merits of investment in the Shares and of making an informed investment decision thereon, and
am not utilizing a purchaser representative in connection with evaluating such risks and merits; or

 

(2)
I and the persons listed in (3) below (not affiliated with the Company) together have such knowledge and experience in financial
and business matters that we are capable of evaluating the merits and risks of investment in the shares and make an informed decision.

 

(Note:
If (1) is correct, cross out (2). If (2) is appropriate (1) and, if (3) below, list, and indicate professional or business relationship
to the undersigned relied upon, or with whom the undersigned consulted, in evaluating the merits and risks investment in the shares.
If such person is serving as a Purchaser Representative of me, have such individual(s) complete a Purchaser Representative Affidavit
obtained from the Company.

 

(3)
In evaluating the merits and risks of investment in the Shares, I have relied upon the advice of, or consulted with, only the
following persons (not affiliated with the Company):

 

(1)
___________________________________________

Name

___________________________________________

Relationship

 

(2)
___________________________________________

Name

___________________________________________

Relationship

 

(i)
I have/have not previously invested in private placement securities (such as stock, equipment leasing, mineral, oil and gas, or
cattle feeding syndications). (CROSS OUT INCORRECT ANSWER.)

 

(j)
I further represent and warrant:

 

(1)
That I hereby agree to indemnify the Company and hold the Company harmless from and against any and all liability, damage, cost,
or expense incurred on account of or arising out of:

 

(A)
Any inaccuracy in my declarations, representations, and warranties hereinabove set forth;

 

    	Term Sheet (Helix TCS)	9

     

    

 

(B)
The disposition of any of the Securities which I will receive, contrary to my foregoing declarations, representations, and warranties;
and

 

(C)
Any action, suit or proceeding based upon (1) the claim that said declarations, representations, or warranties were inaccurate
or misleading or otherwise cause for obtaining damages or redress from the Company; or (2) the disposition of any of the Securities
or any part thereof.

 

(k)
This Agreement shall be construed in accordance with and governed by the laws of the State of Delaware, except as to the manner
in which the subscriber elects to take title to Securities in the Company which shall be construed in accordance with the State
of his principal residence.

 

(l)
Upon request of the Company, I shall provide a sworn and signed copy of my current financial statement.

 

(10)
Subscription:

 

Dollar
amount of notes subscribed for: $____________

 

Total
consideration: $____________

 

Subscriber:

 

Name
(please print) ________________________________

 

Social
Security No. ________________________________

 

Address:
________________________________

 

(including
Zip Code) ________________________________

 

Phone
(___)___________________________

 

Nature
of Business _______________________________

 

Net
Worth $______________________________

 

Liquid
Assets $______________________________

 

(11)
Accredited Investor. I represent that I am an “Accredited Investor”
or an Officer of an “Accredited Investor” as defined below:

 

Accredited
investor shall mean any person who comes within any of the following categories, or who the issuer reasonably believes come
within any of the following categories, at the time of the sale of the securities to that person.

 

(1)
Any bank as defined in section 3(a)(2) of the Act, or any savings and loan association or other institution as defined in section
3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity; any broker or dealer registered pursuant to section
15 of the Securities Exchange Act of 1934; any insurance company as defined in section 2(13) of the Act; any investment company
registered under the Investment Company Act of 1940 or a business development company as defined in section 2(a)(48) of that Act;
any Small Business Investment Company licensed by the U.S. Small Business Administration under section 301(c) or (d) of the Small
Business Investment Act of 1958; any plan established and maintained by a state, its political subdivisions, or any agency or
instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess
of $5,000,000; any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment
decision is made by a plan fiduciary, as defined in section 3(21) of such act, which is either a bank, savings and loan association,
insurance company, or registered investment adviser, or if the employee benefit plan has total assets in excess of $5,000,000
or, if a self-directed plan, with investment decisions made solely by persons that are accredited investors;

 

    	Term Sheet (Helix TCS)	10

     

    

 

(2)
Any private business development company as defined in section 202(a)(22) of the Investment Advisers Act of 1940;

 

(3)
Any organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust,
or partnership, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

(4)
Any director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive
officer, or general partner of a general partner of that issuer;

 

(5)
Any natural person whose individual net worth, or joint net worth with that person’s spouse, at the time of his purchase
exceeds $1,000,000; excluding the market value of primary residence and debt thereon, except in the event the debt exceeds such
primary residence value, such shall be deducted from net worth.

 

(6)
Any natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with
that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same
income level in the current year;

 

(7)
Any trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the securities offered,
whose purchase is directed by a sophisticated person as described in §230.506(b)(2)(ii); and

 

(8)
Any entity in which all of the equity owners are accredited investors.

 

(9)
An entity or person defined under SEC CFR §2330.001 and California Corporations Code §25102(n) (by inclusion).

 

(12)
TITLE:

 

I
will hold title to my note as follows:

 

{  } Community Property

 

{  } Joint Tenants with Right Survivorship

 

{  } Tenants in Common

 

{  } Individually

 

{  } Other: (Corporation, Trust, Etc., please indicate)

 

(Note:
Subscribers should seek the advice of their attorneys in deciding in which of the above forms they should take ownership of the
Note, since different forms of ownership can have varying gift tax and other consequences, depending on the state of the investor’s
domicile and their particular personal circumstances. For example, in community property states, if community property assets
are used to purchase shares held in individual ownership, this might have adverse gift tax consequences. IF OWNERSHIP IS BEING
TAKEN IN JOINT NAME WITH A SPOUSE OR ANY OTHER PERSON, THEN ALL SUBSCRIPTION DOCUMENTS MUST BE EXECUTED BY ALL SUCH PERSONS.)

 

    	Term Sheet (Helix TCS)	11

     

    

 

IN
WITNESS WHEREOF, subject to acceptance by the Company, I have completed this Subscription Agreement to evidence my Subscription
as set forth hereinabove, and I submit herewith a wire transfer/check in the amount of $__________________ for an Unsecured Convertible
Promissory Note of Helix TCS, Inc., this ____day of ______________, 2015.

 

	___________________________________	 	___________________________________
	Subscriber	 	Subscriber
	 	 	 
	Mailing Address:	 	 
	 	 	 
	____________________________________	 	 

 

THIS
SUBSCRIPTION OFFER IS ACCEPTED THIS ______ DAY OF _________________________, 20____.

 

HELIX
TCS, INC.

 

	By:		 

 

    	Term Sheet (Helix TCS)	12

     

    

 

FORM
OF CONVERTIBLE PROMISSORY NOTE

 

NEITHER
THIS SECURED COMMERCIAL PROMISSORY NOTE NOR THE SHARES OF COMMON STOCK UNDERLYING THIS SECURED COMMERCIAL PROMISSORY NOTE WERE
ISSUED IN A REGISTERED TRANSACTION UNDER THE SECURITIES ACT OF 1933 (AS AMENDED, THE "SECURITIES ACT"). THE SECURITIES
EVIDENCED HEREBY MAY NOT BE TRANSFERRED WITHOUT (1) AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER THAT SUCH TRANSFER MAY BE
LAWFULLY MADE WITHOUT REGISTRATION UNDER THE SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAW; OR (ii) SUCH REGISTRATION.

 

UNSECURED

CONVERTIBLE
PROMISSORY NOTE

HELIX
TCS, INC.

 

	$__________ (the “Principal
    Amount")	__________, 2016

 

FOR
VALUE RECEIVED, Helix TCS, Inc. a Delaware corporation (the “Company”), promises to pay to ________________________,
an individual (the “Holder”), the Principal Amount, together with interest at the annual rate of 7%, under
the terms and provisions as set forth below.

 

This
Convertible Promissory Note (this “Note”) is issued by the Company pursuant to a certain Subscription Agreement
by and between the Company and the Holder (the “Subscription Agreement”).

 

The
following is a statement of the rights and obligations of the Holder and the Company under this Note, and the conditions to which
this Note is subject, to which the Company, by the execution and delivery hereof, and the Holder, by the acceptance of this Note,
agree:

 

1.
Definitions. As used in this Note, the following terms, unless the context otherwise requires, have the following meanings:

 

1.1       “Additional
Securities” shall mean all shares of Common Stock issued (or, pursuant to Subsection 4.6.1 below, deemed to be issued)
by the Company after the Note Issuance Date, other than Exempted Securities.

 

1.2       “Company
Sale” shall mean (a) a merger or consolidation of the Company with or into any other Company or other business entity
(except one in which the holders of capital stock of the Company immediately prior to such merger or consolidation continue to
hold at least a majority of the Voting Securities of the surviving Company); (b) a sale, lease, exchange, exclusive license or
other transfer (in one transaction or a related series of transactions) of all or substantially all of the Company’s assets;
or (c) the acquisition by any person or any group of persons (other than the Company, any of its direct or indirect subsidiaries)
acting together in any transaction or related series of transactions, of such number of shares of the Company’s Voting Securities
as causes such person, or group of persons, to own beneficially, directly or indirectly, as of the time immediately after such
transaction or series of transactions, fifty percent (50%) or more of the combined voting power of the Voting Securities of the
Company other than as a result of an acquisition of securities directly from the Company, or solely as a result of an acquisition
of securities by the Company which by reducing the number of shares of the Voting Securities outstanding increases the proportionate
voting power represented by the Voting Securities owned by any such person or group of persons to fifty percent (50%) or more
of the combined voting power of such Voting Securities. This provision shall not be effective until after January 31, 2016, to
allow pending transaction to close.

 

1.3       “Common
Stock” shall mean the Company’s Common Stock,

 

    	Term Sheet (Helix TCS)	13

     

    

 

1.4       “Conversion
Amount” shall mean (a) that part of the outstanding Principal Amount of this Note which the Holder elects to convert
to common shares in the Company @ a 20% discount to the average market closing price for the five trading days preceding the date
of conversion election, or under the terms of the mandatory conversion set forth hereinafter (in increments of $1,000.00 up to
the entire outstanding Principal Amount) and, if an election is so made pursuant to Section 4.1 herein, (b) all accrued and unpaid
interest.

 

1.5       “Conversion
Date” shall mean any date on which the Conversion Amount shall be converted into Conversion Shares.

 

1.6       “Conversion
Price” shall mean a conversion to common stock, at a discount of 20% from the average market closing price for the common
stock for the five days preceding the conversion election, or under the terms of mandatory conversion as hereinafter set forth,
subject to adjustment as set forth in Subsection 4.6 herein.

 

1.7       “Convertible
Securities” shall mean any evidences of indebtedness, shares, or other securities directly or indirectly convertible
into or exchangeable for Common Stock, but excluding Options.

 

1.8       “Conversion
Shares” means the shares of the capital stock of the Company, which may be received upon conversion of this Note pursuant
to conversion under Section 4.1 herein.

 

1.9       “Exempted
Securities” shall mean, collectively, (a) the following shares of Common Stock and (b) shares of Common Stock deemed
issued pursuant to the following Options and Convertible Securities:

 

shares
of Common Stock, Options, or Convertible Securities issued by reason of a dividend, stock split, split-up or other distribution
on shares of Common Stock that is covered by Subsection 4.6.8, 4.6.9 or 4.6.10; or

 

shares
of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of Common Stock actually issued
upon the conversion or exchange of Convertible Securities, in each case provided such issuance is pursuant to the terms of such
Option or Convertible Security.

 

1.10       “Note
Issuance Date” shall mean the date of the issuance of the Note.

 

1.11       “Option”
shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.

 

1.12       “Transaction
Agreements” shall mean the Subscription Agreement, and the documents executed and delivered in connection with the Subscription
Agreement.

 

1.13       “Voting
Securities” shall mean the outstanding capital stock having the right to vote in an election of the Board of Directors.

 

2.
Payments.

 

2.1       Maturity
Date. Unless earlier converted pursuant to Section 4 below, or earlier paid pursuant to Section 5 below, the Principal Amount
and all accrued interest on the Note shall become due and payable on December 31, 2017 (the “Maturity Date”)
at the Holder’s address as set forth on the signature page hereto with no further notice being required by the Holder. Upon
the payment in full of the Note, the Holder shall promptly surrender the Note to or as directed by the Company.

 

    	Term Sheet (Helix TCS)	14

     

    

 

2.2       Acceleration
on Event of Default. Notwithstanding Section 2.1 hereof, the entire unpaid Principal Amount and accrued and unpaid interest
on this Note and on all of the Notes shall be immediately due and payable upon an Event of Default (as defined in Section 6 hereof).

 

2.3       Interest.
This Note shall bear interest at the rate of seven percent (7.0%) per annum, computed on a 365-day year basis, and shall accrue
daily from the Note Issuance Date. Interest shall be due and payable to the Holder in annual installments, beginning on December
31, 2016, with a final installment of all unpaid principal and accrued and unpaid interest on the Maturity Date. Each payment
shall be applied first to any fees, costs, or expenses of Holder, then to interest, and the balance to the Principal Amount. Any
interest payments due to the Holder hereunder shall be paid without withholding of any taxes or relief.

 

2.4       Default
Interest. Any amount, whether the Principal Amount, accrued interest, or fees and expenses, that is not paid when due (whether
at the Maturity Date, by acceleration, or otherwise), shall bear interest daily from the date on which such Principal Amount,
accrued interest, and/or fees and expenses is due until such Principal Amount, accrued interest, and all fees and expenses of
this Note are paid in full, at the rate of twelve percent (12%) per annum.

 

3.       Security
and Collateral. The payment obligations of the Company under this Note are NOT secured by any security interest in assets
of the Company.

 

4.       Conversion.

 

4.1       Optional
& Mandatory Conversion. The principal balance of this Convertible Promissory Note is convertible into Common Stock of
the Company. The conversion rights shall be adjusted in the event of any merger, consolidation, reorganization recapitalization,
reverse, or forward split under the terms hereof.

 

Elective
Conversion: The principal balance of the Note shall be convertible at the election of the holder of Note, in whole or in part,
at any time and from time to time, into the Company’s common stock at a 20% discount to the average market closing price
for the previous 5 trading days, preceding the date that the notice of conversion is delivered to the Company in writing, subject
to a minimum conversion price of $.20 per share.

 

The
accrued interest of the Note may be converted into the Company’s Common Stock at noteholders option, if registered common
shares are available.

 

In
connection with an elective conversion pursuant to this Section 4.1, the Holder shall enter into customary stock purchase agreements
and related investment documents that are mutually agreeable to the Holder and the Company. This note may be converted in increments
of $1,000 This Note shall be cancelled effective upon the closing of full conversion and all rights with respect to payment of
principal and interest under this Note shall immediately cease and terminate effective with such closing, except only the right
of the Holder to receive shares, as applicable, in exchange for this cancelled Note.

 

Mandatory
Conversion: The principal balance of the Note shall also automatically convert into shares of Common Stock upon the completion
of the following event (the “Conversion Event”):

 

(a)
if the Company applies for an Exchange listing and the Company shall have an effective S-1 registration with the Securities and
Exchange Commission (“SEC”).

 

    	Term Sheet (Helix TCS)	15

     

    

 

(b)
upon the occurrence of the Conversion Event, the Note shall automatically convert, without further notice to or action by any
person, into an equivalent number of shares of the Company’s common stock at a 20% discount to the average market closing
price for the previous 5 trading days preceding the effective date of the S-1 registration. The date of conversion of the Note
shall be the date on which the mandatory conversion event above has been accomplished. (A Mandatory Conversion shall take not
take place unless the underlying shares of common stock of the Company are covered by an effective registration statement filed
by the Company with the SEC).

.

4.2       Mechanics
of Conversion. As soon as practicable after a conversion of this Note pursuant to Section 4.1, the Company at its expense
will cause to be issued in the name of and delivered to the Holder of this Note the Conversion shares to which the Holder shall
be entitled on such conversion (bearing such legends as may be required by any agreements which may be entered into by the Holder
in connection with such conversion and applicable state and federal securities laws). No fractional shares will be issued on conversion
of this Note. If a fraction of a share would otherwise be issuable on conversion of this Note, the Company will in lieu of such
issuance pay the cash value of that fractional share. The Company shall issue certificates evidencing the Conversion shares issuable
upon a conversion when this Note is either delivered to the Company, duly endorsed, at the office of the Company, or the Holder
notifies the Company that the Note has been lost, stolen, or destroyed and executes an agreement satisfactory to the Company to
indemnify the Company from any loss incurred by it in connection with the Note. As soon as practicable after delivery of the Note,
or delivery of an agreement and indemnification in the case of a lost Note, the Company shall issue and deliver to the Holder
(a) certificates for the Conversion shares to which the Holders shall be entitled, and (b) an amount equal to the cash amounts
payable as a result of any fractional share adjustment of such Conversion shares. The Holder shall be treated for all purposes
as the record holder of such Conversion shares on the Conversion Date.

 

4.3       Obligation
Absolute. The Company’s obligations to issue and deliver the Conversion shares upon conversion of this Note in accordance
with the terms hereof are absolute and unconditional, irrespective of any action or inaction by the Holder to enforce the same,
any waiver or consent with respect to any provision hereof, the recovery of any judgment against any person or any action to enforce
the same, or any setoff, counterclaim, recoupment, limitation, or termination, or any breach or alleged breach by the Holder or
any other person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other person,
and irrespective of any other circumstance which might otherwise limit such obligation of the Company to the Holder in connection
with the issuance of such Conversion shares; Nothing herein shall limit the Holder’s right to pursue actual damages or declare
an Event of Default under this Note, pursuant to Section 6 herein and the Holder shall have the right to pursue all remedies available
to her at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

4.4       Reservation
of Shares Issuable Upon Conversion. The Company covenants that it shall at all times reserve and keep available out of its
authorized and unissued shares of Common Stock, solely for the purpose of issuance upon conversion of the Note, as herein provided,
free from preemptive rights or any other actual contingent purchase rights of persons other than the Holder, not less than such
number of shares of the Common Stock as shall be issuable, upon the conversion of the Conversion Amount of the Note. The Company
covenants that all shares of Common Stock that shall be so issued upon conversion of this Note shall, upon such issue, be duly
and validly authorized, issued and fully paid, and non-assessable.

 

4.5       Transfer
Taxes. The issuance of certificates for Shares of the Common Stock and Warrants on conversion of the Note shall be made without
charge to the Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such
certificate, provided that the Company shall not be required to pay any tax that may be payable in respect of any transfer involved
in the issuance and delivery of any such certificate upon conversion in a name other than that of the Holder of the Note so converted,
and the Company shall not be required to issue or deliver such certificates unless or until the person or persons requesting the
issuance thereof shall have paid to the Company the amount of such tax or shall have established to the satisfaction of the Company
that such tax has been paid. If Conversion shares are to be issued in the name of a person other than the Holder, the Holder will
pay all transfer taxes payable with respect thereto and is delivering herewith such certificates and opinions as reasonably requested
by the Company in accordance therewith. No fee will be charged to the Holder for any conversion, except for such transfer taxes,
if any.

 

    	Term Sheet (Helix TCS)	16

     

    

 

4.6.       Adjustment
for Stock Splits and Combinations. If the Company shall at any time or from time to time after the Note Issuance Date effect a
subdivision of the outstanding Common Stock, the Conversion Price in effect immediately before that subdivision shall be proportionately
decreased so that the number of Conversion shares issuable on conversion of this Note shall be increased in proportion to such
increase in the aggregate number of shares of Common Stock outstanding. If the Company shall at any time or from time to time
after the date of this Note combine the outstanding shares of Common Stock, the Conversion Price in effect immediately before
the combination shall be proportionately increased so that the number of Conversion shares issuable on conversion of this Note
shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment
under this subsection shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

5.       Redemption.
If, on the 2nd Anniversary the Note has not been converted into common stock, then the Company may redeem the Note in one of two
methods, as elected by the Holder of such Note in their sole discretion:

 

(a)
The Company shall redeem the Note by paying Holder the cash amount $2.00 per every one dollar of unconverted note held, plus any
accrued and unpaid dividends.

 

In
the event that the Company is unable to effect such cash redemption as elected by a Holder, then the Company shall issue to the
Note Holder (“Holder”) on the date of redemption a senior secured note obligating the Company to pay the redemption
amount to Holder on terms not to exceed twelve (12) months at an interest rate of fourteen percent (14%) per annum.

 

or

 

(b)
If the Company is eligible for Exchange listing and has filed an Exchange Application, the Company shall issue shares of common
stock (which must be covered by an effective registration statement filed by the Company with the SEC) to the Holder. The number
of shares of common stock for each dollar of unconverted Note shall be calculated as follows:

 

(i)
If the average quoted closing bid price, if any, for the preceding 10 trading days with an average trading volume of at least
$20,000 a day is $1.00 or more, then the Company shall issue 2 shares of common stock for each $1.00 of unpaid Note principal.

 

(ii)
If the fully diluted fair market value of the Common Stock (or average quoted closing bid price, if any, for the preceding 10
trading days with an average trading volume of at least $20,000 a day) is less than $1.00, then by dividing $1.00 by the value
(or price) of the common stock by and issuing that number of shares equal to a 2X gain based on the closing bid price (i.e. if
the price of the common stock is $0.50, then 4 shares of common stock would be issued; if $0.25, then 8 shares).

 

The
Company shall notify Holder of the Redemption Date at least 90 days prior to the Redemption Date. The Holder shall make such election
at least 30 days prior to the Redemption Date. If the Holder fails to make any election, then the Company may make such election
at the Company’s discretion.

 

    	Term Sheet (Helix TCS)	17

     

    

 

In
the event of a sale of all of the capital stock of the Company after a pending merger, or substantially all of the assets of the
Company, the Company shall redeem any unconverted Note principal on the closing date of the sale at a rate of $1.50 per dollar
of unpaid principal in cash (or the equivalent in securities, as referenced below), plus payment in cash or shares of any accrued
and unpaid dividends. However, if the sale price (or participation in the sale) for the fully diluted common stock of the Company
is more than $1.00 per share of common stock, then any unconverted Note balance shall convert at a 2:1 ratio into common stock
immediately prior to the closing of the sale for a 2x Liquidation Preference for each Note Holder.

 

If
the sale price is a combination of cash and securities of the purchaser, then the Holders of Note shall be paid as if converted
@ $1.00 in the same ratio of cash to securities as the other Holders of common stock for a 2x Liquidation Preference. If the securities
of the purchaser are subject to any restriction (i.e. unregistered or lock-up), the sale transaction shall be subject to a shareholder
vote, with Note Holder having a vote equal to the number of shares of common as if converted at $1.00 for a 2x Liquidation Preference.

 

6.       Events
of Default.

 

6.1       Event
of Default. Wherever used herein, “Event of Default” means any one or more of the following events (whatever
the reason and whether it shall be voluntary or involuntary or effected by operation of law or pursuant to any judgment, decree,
or order of any court, or any order, rule or regulation of any administrative or governmental body):

 

(a)       any
default in the payment of (i) the principal amount of the Note, or (ii) any interest on the Note; or (iii) other fees owing on
the Note, as and when the same shall become due and payable (whether on the Maturity Date or by acceleration or otherwise) which
default, solely in the case of defaults under clause (iii) above, is not cured, within twenty (20) days;

 

(b)       the
Company shall fail to observe or perform any other covenant or agreement contained in this Note which failure is not cured, if
possible to cure, within the earlier to occur of (i) thirty (30) days after notice of such default sent by the Holder and (ii)
forty-five (45) days after the Company shall become or should have become aware of such failure;

 

(c)       (i)
the Company shall commence a case, as debtor, under any applicable bankruptcy or insolvency laws as now or hereafter in effect
or any successor thereto, or the Company commences any other proceeding under any reorganization, arrangement, adjustment of debt,
relief of debtors, dissolution, insolvency, or liquidation or similar law of any jurisdiction whether now or hereafter in effect
relating to the Company, or (ii) there is commenced a case against the Company, under any applicable bankruptcy or insolvency
laws, as now or hereafter in effect or any successor thereto, which remains undismissed for a period of ninety (90) days; or (iii)
the Company is adjudicated by a court of competent jurisdiction insolvent or bankrupt; or any order of relief or other order approving
any such case or proceeding is entered; or (iv) the Company suffers any appointment of any custodian, receiver, trustee, or the
like for it or any substantial part of its property which continues undischarged or unstayed for a period of ninety (90) days;
or (v) the Company makes a general assignment for the benefit of creditors; or (vi) the Company shall fail to pay, or shall state
that it is unable to pay, or shall be unable to pay, its debts generally as they become due; or (vii) any corporate or other action
is taken by the Company for the purpose of effecting any of the foregoing;

 

(d)       the
Company shall default (following the failure to cure as provided in any applicable agreement described in this Section 6.1(d))
in an amount exceeding $100,000 in any of its payment obligations under any credit agreement or other facility, indenture agreement,
or other instrument under which may be issued, or by which there may be secured or evidenced any indebtedness for borrowed money
or money due under any long term leasing or factoring arrangement of the Company, whether such indebtedness now exists or shall
hereafter be created and such default shall result in such indebtedness becoming or being declared due and payable prior to the
date on which it would otherwise become due and payable, with the exception of mortgages collateralized by real estate and which
such outstanding loan is less than 50% of the value of the collateral;

 

    	Term Sheet (Helix TCS)	18

     

    

 

(e)       The
issuance of any order or decree enjoining or prohibiting the Company from performing under this Note or any of the Transaction
Agreements, which order or decree is not vacated within fifteen (15) days after the granting thereof;

 

(f)       The
occurrence of any event or condition, that with the giving of notice or passage of time, or both, could result in a material default
by the Company under any other contract, loan, obligation or agreement of any kind to which the Company is a party that results
in a material adverse effect against the Company;

 

(g)       The
occurrence of any event or condition that Holder, in reasonable judgment, believes results in a material adverse effect against
the Company.

 

6.2       Remedies
Upon Event of Default. If any Event of Default occurs, the full Principal Amount of this Note, accrued interest, fees and
expenses, together with other amounts owing pursuant hereto, to the date of acceleration shall become, at the Holder’s election,
immediately due and payable in cash. Commencing twenty (20) days after the occurrence of any Event of Default that results in
the eventual acceleration of this Note, the interest rate on this Note shall accrue daily at the rate of twelve percent (12%)
per annum, and such interest shall be added to the Principal Amount monthly. The Holder need not provide, and the Company hereby
waives, any presentment, demand, protest, or other notice or demands of any kind, and the Holder may immediately and without expiration
of any grace period enforce any and all of its rights and remedies hereunder and all other remedies available to it under applicable
law. Such declaration may be rescinded and annulled by Holder at any time prior to payment hereunder and the Holder shall have
all rights as a Holder until such time, if any, as the full payment under this Section shall have been received by it. No such
rescission or annulment shall affect any subsequent Event of Default or impair any right consequent thereon.

 

7.       Transfer
Restrictions. The Holder shall not sell, transfer, convey, or assign the Note until: (a) it has first given written notice
to the Company, describing briefly the manner of any such proposed transfer; and (b) (i) it has provided the Company, at the Holder’s
sole expense, an opinion satisfactory to the Company both in substance and as to the counsel providing such opinion, that such
transfer can be made without compliance with the registration requirements of the Securities Act, and applicable state securities
laws, or (ii) a registration statement filed by the Company under the Securities Act and applicable state securities laws registering
the sale of the Notes by the Holders is declared effective by the Securities and Exchange Commission and state securities commissions
having jurisdiction (except, in each case, (y) a transfer of the Note directly to or in trust for the primary benefit of the Holder,
the spouse of the Holder, and/or the issue of the Holder and/or her spouse, and (ii) in the event of the death of the Holder,
a transfer of the Note from the name of the deceased Holder to the name of either the personal representative of the deceased
Holder’s estate or the nominee of such personal representative and any subsequent transfer to the heirs or legatees of the
deceased Holder).

 

8.       Currency;
Payments. All references herein to “dollars” or “$” are to U.S. dollars, and all payments of principal
of, and interest on, this Note shall be made in lawful money of the United States of America in immediately available funds. If
the date on which any such payment is required to be made pursuant to the provisions of this Note occurs on a Saturday or Sunday
or legal holiday observed in the State of Delaware, such payments shall be due and payable on the immediately succeeding date
which is not a Saturday or Sunday or legal holiday so observed.

 

    	Term Sheet (Helix TCS)	19

     

    

 

9.       Right
of Prepayment. The Company may prepay the Principal Amount of this Note, in whole or in part, without penalty, and any partial
prepayments shall be applied to installments under this Note in the reverse order of their stated maturities.

 

10.       Miscellaneous.

 

10.1       Time
of Essence. Time is of the essence with respect to the Company’s duties and obligations under this Note.

 

10.2       Amendments
and Waivers. No term of the Note may be amended or compliance therewith waived (either generally or in a particular instance
and either retroactively or prospectively) without the written consent of the Company and the Holder.

 

10.3       Severability.
If one or more provisions of this Note are held to be unenforceable under applicable law, such provision shall be excluded from
this Note and the balance of the Note shall be interpreted as though such provision were so excluded and shall be enforceable
in accordance with its terms. The parties agree to replace such illegal, void, invalid, or unenforceable provision of this Note
with a legal, valid, and enforceable provision that shall achieve, to the extent possible, the economic, business, and other purposes
of such illegal, void, invalid or unenforceable provision.

 

10.4       Attorneys’
Fees and Costs. Each party shall bear its own expenses in connection with the issuance of this Note; provided, however,
that if any action at law or in equity is necessary to enforce or interpret the terms of this Note, the prevailing party shall
be entitled to its attorneys’ fees, costs, and disbursements in addition to any other relief to which such party may be
entitled. As used in this Section, attorneys’ fees shall be deemed to mean the full and actual costs of any legal services
actually performed in connection with the matters involved calculated on the basis of the usual fee charged by the attorney performing
such services and shall not be limited to “reasonable attorneys’ fees” as defined in any statute or rule of
court.

 

10.5       Entire
Agreement. This Note, together with the Transaction Agreements delivered in connection herewith, constitutes the entire agreement
between the parties hereto with respect to the subject matter hereof and supersedes all prior and contemporaneous negotiations,
agreements, and understandings (including any “term sheets” or similar documents).

 

10.6       Notices.
Any notice or communication required or permitted by this Agreement shall be given in writing and addressed as follows:

 

	 	If to
    the Company:	Helix TCS, Inc.

 

If
to the Holder: 

 

Notices
shall be served personally, by overnight express mail service by a nationally recognized courier, or first-class, certified mail,
return receipt requested, postage pre-paid. If sent personally, notice shall be deemed delivered upon receipt. If sent by overnight
express mail service, notice shall be deemed delivered 24 hours after delivery into the possession and control of the courier.
If sent by first-class, certified mail, return receipt requested, notice shall be deemed delivered the earlier of seventy-two
(72) hours after mailing or the date on the return receipt, a refusal being deemed a delivery on the date of refusal. If the party
to whom any such notice is sent has relocated without leaving a forwarding address, then the notice shall be deemed delivered
on the date the notice-receipt is returned stating that the same was undeliverable at such address. Any party may give notification
to the other party in any manner described above for change of address for the sending of notices.

 

    	Term Sheet (Helix TCS)	20

     

    

 

10.7       Successors
and Assigns. This Note shall be binding upon and inure to the benefit of the Company and the Holder and their respective successors
and permitted assigns. The Company may not voluntarily or involuntarily transfer, convey, or assign this Note, or any of its duties
or obligations hereunder, without the Holder’s prior written consent, which may be withheld for any reason, or for no reason
at all. As used herein, the term “Holder” shall mean and include the successors and permitted assigns of the Holder.

 

10.8       Absolute
Obligation. Except as expressly provided herein, no provision of this Note shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the Principal Amount and accrued interest of, and liquidated damages (if any) on,
this Note at the time, place, and rate, and in the currency, herein prescribed. This Note is a direct debt obligation of the Company.

 

10.9       Lost
or Mutilated Note. If this Note shall be mutilated, lost, stolen, or destroyed, the Company shall execute and deliver, in
exchange and substitution for and upon cancellation of a mutilated Note, or in lieu of or in substitution for a lost, stolen,
or destroyed Note, a new Note for the Principal Amount of this Note so mutilated, lost, stolen, or destroyed but only upon receipt
of evidence of such loss, theft, or destruction of such Note, and of the ownership hereof, and indemnity, if requested, all reasonably
satisfactory to the Company.

 

10.10       Usury.
If it shall be found that any interest or other amount deemed interest due hereunder violates applicable laws governing usury,
the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum permitted rate of interest.
The Company covenants (to the extent that it may lawfully do so) that it shall not at any time insist upon, plead, or in any manner
whatsoever claim or take the benefit or advantage of, any stay, extension, or usury law or other law which would prohibit or forgive
the Company from paying all or any portion of the Principal Amount of or interest on this Note as contemplated herein, wherever
enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this indenture, and the
Company (to the extent it may lawfully do so) hereby expressly waives all benefits or advantage of any such law, and covenants
that it shall not, by resort to any such law, hinder, delay, or impede the execution of any power herein granted to the Holder,
but shall suffer and permit the execution of every such as though no such law has been enacted.

 

10.11       Headings.
The headings contained herein are for convenience only, do not constitute a part of this Note, and shall not be deemed to limit
or affect any of the provisions hereof.

 

10.12       Governing
Law; Venue. This Note is to be governed by and interpreted in accordance with the laws of the State of Delaware. Any legal
action or proceeding with respect to this Note or any document related hereto shall be brought in the Jefferson County, Colorado
Circuit Court or any court of the United States of America for the District of Colorado, and, by execution and delivery of this
Note, the Company hereby accepts for itself and in respect of its property, generally and unconditionally, the jurisdiction of
such courts.

 

[The
remainder of this page left intentionally blank. Signature page immediately follows.]

 

    	Term Sheet (Helix TCS)	21

     

    

 

The
Company has caused this Note to be signed in its name and executed as a sealed instrument as of the date first written above.

 

	 	HELIX
    TCS, INC.
	 	 	 	 
	 	By:	 	 
	 	 	Name:	 
	 	 	Title:	Chief
    Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Signature
page to Convertible Promissory Note

 

 

 

 

 

 

	Term Sheet (Helix TCS)	22SECURITIES
PURCHASE AGREEMENT

 

This
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 7, 2017, by and between Endonovo Therapeutics,
Inc., a Delaware corporation, with headquarters located at 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA 91367,
(the “Company”), and EAGLE EQUITIES, LLC, a Nevada limited liability company, with its address at 91 Shelton
Ave, Suite 107, New Haven, CT 06511 (the “Buyer”).

 

WHEREAS:

 

A.
The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”)
under the Securities Act of 1933, as amended (the “1933 Act”);

 

B.
Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement
ten 10% convertible notes of the Company, in the forms attached hereto as Exhibit A through J in the aggregate principal amount
of $2,120,000.00 (with the first note being in the amount of $210,000 and the rest of the nine notes being in the amounts of $210,000)
(together with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance
with the terms thereof, the “Note”), convertible into shares of common stock, of the Company (the “Common Stock”),
upon the terms and subject to the limitations and conditions set forth in such Note. Each note shall contain an original issue
discount of 5% such that the purchase price of each note shall be $200,000.00. The notes identified as Notes 1, 3, 5, 7, and 9,
on page 2 of this Agreement, shall be paid for by the Buyer as set forth herein. The notes identified as Notes 2, 4, 6, 8, and
10, on page 2 of this Agreement, are each referred to as a “Back End Note”. Each Back End Note shall initially be
paid for by the issuance by the Buyer of an offsetting full recourse promissory note issued to the Company in an amount not less
than the amount of the Back End Note.

 

C.
The Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of Note as is set
forth immediately below its name on the signature pages hereto; and

 

NOW
THEREFORE, the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1.
Purchase and Sale of Note.

 

a.
Purchase of Note. On each Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer
agrees to purchase from the Company such principal amount of Note as is set forth immediately below the Buyer’s name on
the signature pages hereto.

 

_____

Company Initials

 

    	 

    	 

    

 

b.
Form of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Note to be
issued and sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available
funds to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Note in the
principal amount equal to the Purchase Price as is set forth immediately below the Buyer’s name on the signature pages hereto,
and (ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against delivery of such Purchas
Price.

 

c.
Closing Date. The date and time of the first issuance and sale of the Note pursuant to this Agreement (the “Closing
Date”):

 

	Note Type	Issue Date	Cash Funding Date
	$210,000 front End (Note 1)	April 7, 2017	April 10, 2017
	$210,000 back end (Note 2)	April 7, 2017	December 7, 2017
	$210,000 front end 2 (Note 3)	May 7, 2017	 May 7, 2017
	$210,000 back end 2 (Note 4)	May 7, 2017	 January 7, 2018
	$210,000 front end 3 (Note 5)	June 7, 2017	 June 7, 2017
	$210,000 back end 3 (Note 6)	June 7, 2017	 February 7, 2018
	$210,000 front end 4 (Note 7)	July 7, 2017	 July 7, 2017
	$210,000 back end 4 (Note 8)	July 7, 2017	 March 7, 2018
	$210,000 front end 5 (Note 9)	 August 7, 2017	 August 7, 2017
	$210,000 back end 5 (Note 10)	 August 7, 2017	 April 7, 2018

 

 

The
Closing of each Note shall be contingent on the following conditions: (i) the Company must be current in its filings, (ii) the
Company must have a “bid” price for its stock, (iii) the Company must have reserve available equal to 4x the discounted
value of each front end note at the time of funding and 3x the discounted value of each back end note or a reasonable plan to
create the same and is proceeded in good faith with such filings and approvals necessary to fulfill the reserve. The Buyer shall
have the right to accelerate the purchase of the Notes and shall also be granted a five (5) day grace period for each purchase.

 

2.
Buyer’s Representations and Warranties. The Buyer represents and warrants to the Company that:

 

    	2 

    	 

    

 

a.
Investment Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon
conversion of or otherwise pursuant to the Note, such shares of Common Stock being collectively referred to herein as the “Conversion
Shares” and, collectively with the Note, the “Securities”) for its own account and not with a present view towards
the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act;
provided, however, that by making the representations herein, the Buyer does not agree to hold any of the Securities
for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant
to a registration statement or an exemption under the 1933 Act.

 

b.
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D (an “Accredited Investor”). Any of Buyer’s transferees, assignees, or purchasers must be “accredited
investors” in order to qualify as prospective transferees, permitted assignees in the case of Buyer’s or Holder’s
transfer, assignment or sale of the Note.

 

c.
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying
upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments
and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility
of the Buyer to acquire the Securities.

 

d.
Information. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue
to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to
the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any,
have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the
Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will
not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure
to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives
shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section
3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware
of any facts that may constitute a breach of any of the Company’s representations and warranties made herein.

 

e.
Governmental Review. The Buyer understands that no United States federal or state agency or any other government or governmental
agency has passed upon or made any recommendation or endorsement of the Securities.

 

    	3 

    	 

    

 

f.
Transfer or Re-sale. The Buyer understands that (i) the sale or re-sale of the Securities has not been and is not being
registered under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a) the
Securities are sold pursuant to an effective registration statement under the 1933 Act, (b) in the case of subparagraphs (c),
(d) and (e) below, the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be
in form, substance and scope customary for opinions of counsel in comparable transactions to the effect that the Securities to
be sold or transferred may be sold, or transferred pursuant to an exemption from such registration, including the removal of any
restrictive legend which opinion shall be accepted by the Company, (c) the Securities are sold or transferred to an “affiliate”
(as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”) of the Buyer who agrees
to sell or otherwise transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor, (d)
the Securities are sold pursuant to Rule 144, or (e) the Securities are sold pursuant to Regulation S under the 1933 Act (or a
successor rule) (“Regulation S”); (ii) any sale of such Securities made in reliance on Rule 144 may be made only in
accordance with the terms of said Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances
in which the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined
in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder;
and (iii) neither the Company nor any other person is under any obligation to register such Securities under the 1933 Act or any
state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case).

 

g.
Legends. The Buyer understands that the Note and, until such time as the Conversion Shares have been registered under the
1933 Act will be sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular
date that can then be immediately sold, the Conversion Shares may bear a restrictive legend in substantially the following form
(and a stop-transfer order may be placed against transfer of the certificates for such Securities):

 

“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. “

 

    	4 

    	 

    

 

The
legend set forth above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security
upon which it is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for
sale under an effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation
S without any restriction as to the number of securities as of a particular date that can then be immediately sold, and (b) such
holder provides the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable
transactions, to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act,
and that legend removal is appropriate, which opinion shall be accepted by the Company so that the sale or transfer is effected.
The Buyer agrees to sell all Securities, including those represented by a certificate(s) from which the legend has been removed,
in compliance with applicable prospectus delivery requirements, if any. In the event that the Company does not accept the opinion
or provide an acceptable opinion of counsel provided by the Buyer with respect to the transfer of Securities pursuant to an exemption
from registration, such as Rule 144 or Regulation S, within 2 business days, it will be considered an Event of Default under the
Note.

 

h.
Authorization; Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed
and delivered on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in
accordance with its terms.

 

i.
Residency. The Buyer is a resident of the jurisdiction set forth immediately below the Buyer’s name on the signature
pages hereto.

 

j.
No Short Sales. Buyer/Holder, its successors, affiliates and assigns, agree that so long as the Note remains outstanding,
the Buyer/Holder shall not enter into or effect “short sales” of the Common Stock or hedging transaction which establishes
a short position with respect to the Common Stock of the Company. The Company acknowledges and agrees that upon delivery of a
Conversion Notice by the Buyer/Holder, the Buyer/Holder immediately owns the shares of Common Stock described in the Conversion
Notice and any sale of those shares issuable under such Conversion Notice would not be considered short sales.

 

h.
Trading Limitations. The Buyer shall limit is sales of Common Stock convertible under this Note (“Convertible Shares”)
such that in no single trading day shall the Buyer sell Convertible Shares in excess of the greater of $10,000 or 20% of the aggregate
trading volume of the Company Common Stock on that trading day all sales shall be made through one broker/dealer and the trading
limitation shall be acknowledged by Buyer’s broker/dealer.

 

3.
Representations and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

    	5 

    	 

    

 

a.
Organization and Qualification. The Company and each of its subsidiaries, if any, is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted.

 

b.
Authorization; Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this
Agreement, the Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance
with the terms hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation
by it of the transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance
and reservation for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized
by the Company’s Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its
shareholders is required, (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative,
and such authorized representative is the true and official representative with authority to sign this Agreement and the other
documents executed in connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution
and delivery by the Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the
Company enforceable against the Company in accordance with its terms.

 

c.
Issuance of Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note
in accordance with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens,
claims and encumbrances with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights
of shareholders of the Company and will not impose personal liability upon the holder thereof.

 

d.
Acknowledgment of Dilution. The Company understands and acknowledges the potentially dilutive effect to the Common Stock
upon the issuance of the Conversion Shares upon conversion of the Note. The Company further acknowledges that its obligation to
issue Conversion Shares upon conversion of the Note in accordance with this Agreement, the Note is absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

e.
No Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for
issuance of the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of
Incorporation or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default
(or an event which with notice or lapse of time or both could become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company
or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws and regulations and regulations of any self-regulatory organizations to which the
Company or its securities are subject) applicable to the Company or any of its Subsidiaries or by which any property or asset
of the Company or any of its Subsidiaries is bound or affected (except for such conflicts, defaults, terminations, amendments,
accelerations, cancellations and violations as would not, individually or in the aggregate, have a Material Adverse Effect). All
consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date hereof. The Company is not in violation of the listing requirements
of the OTC Markets Exchange (the “OTC MARKETS”) and does not reasonably anticipate that the Common Stock will be delisted
by the OTC MARKETS in the foreseeable future, nor are the Company’s securities “chilled” by FINRA. The Company
and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

    	6 

    	 

    

 

f.
Absence of Litigation. Except as disclosed in the Company’s Periodic Report filings with the SEC, there is no action,
suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or
any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect.
Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened
proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse
effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

g.
Acknowledgment Regarding Buyer’ Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting
solely in the capacity of arm’s length purchasers with respect to this Agreement and the transactions contemplated hereby.
The Company further acknowledges that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to this Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of
its respective representatives or agents in connection with this Agreement and the transactions contemplated hereby is not advice
or a recommendation and is merely incidental to the Buyer’ purchase of the Securities. The Company further represents to
the Buyer that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation of
the Company and its representatives.

 

h.
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has
directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances
that would require registration under the 1933 Act of the issuance of the Securities to the Buyer.

 

i.
Title to Property. The Company and its subsidiaries have good and marketable title in fee simple to all real property and
good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries,
in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 3(i) or such as would
not have a material adverse effect. Any real property and facilities held under lease by the Company and its subsidiaries are
held by them under valid, subsisting and enforceable leases with such exceptions as would not have a material adverse effect.

 

j.
Bad Actor. No officer or director of the Company would be disqualified under Rule 506(d) of the Securities Act as amended
on the basis of being a “bad actor” as that term is established in the December 19, 2013 Small Entity Compliance Guide
published by the Securities and Exchange Commission.

 

k.
Breach of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties
set forth in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will
be considered an Event of default under the Note.

 

    	7 

    	 

    

 

4.
COVENANTS.

 

a.
Expenses. At the Closing, the Company shall reimburse Buyer for expenses incurred by them in connection with the negotiation,
preparation, execution, delivery and performance of this Agreement and the other agreements to be executed in connection herewith
(“Documents”), including, without limitation, reasonable attorneys’ and consultants’ fees and expenses,
transfer agent fees, fees for stock quotation services, fees relating to any amendments or modifications of the Documents or any
consents or waivers of provisions in the Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of
restructuring the transactions contemplated by the Documents. When possible, the Company must pay these fees directly, otherwise
the Company must make immediate payment for reimbursement to the Buyer for all fees and expenses immediately upon written notice
by the Buyer or the submission of an invoice by the Buyer.

 

b.
Listing. The Company shall promptly secure the listing of the Conversion Shares upon each national securities exchange
or automated quotation system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance)
and, so long as the Buyer owns any of the Note Securities, shall maintain, so long as any other shares of Common Stock shall be
so listed, such listing of all Conversion Shares from time to time issuable upon conversion of the Note. The Company will obtain
and, so long as the Buyer owns any of the Securities, maintain the listing and trading of its Common Stock on the OTC MARKETS
or any equivalent replacement market, the Nasdaq stock market (“Nasdaq”), the New York Stock Exchange (“NYSE”),
or the American Stock Exchange (“AMEX”) and will comply in all respects with the Company’s reporting, filing
and other obligations under the bylaws or rules of the Financial Industry Regulatory Authority (“FINRA”) and such
exchanges, as applicable. The Company shall promptly provide to the Buyer copies of any notices it receives from the OTC MARKETS
and any other markets on which the Common Stock is then listed regarding the continued eligibility of the Common Stock for listing
on such markets.

 

c.
Corporate Existence. So long as the Buyer beneficially owns the Note, the Company shall maintain its corporate existence
and shall not sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or
sale of all or substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i)
assumes the Company’s obligations hereunder and under the agreements and instruments entered into in connection herewith
and (ii) is a publicly traded corporation whose Common Stock is listed for trading on the OTC MARKETS, Nasdaq, NYSE or AMEX.

 

    	8 

    	 

    

 

d.
No Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances
that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause the offering of
the Securities to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval
provision applicable to the Company or its securities.

 

e.
Exclusivity. For a period of 12 months following the issuance of each of the Notes the Buyer shall have the exclusive right
to fund the Company with any convertible financing or a registered offering of securities, including an ELOC. If the Company consummates
a convertible financing or an ELOC with another party without prior consent of the Buyer, the Investor shall not be obligated
to fund the balance of the Notes, listed on page 2 that have not already been funded.

 

f.
Breach of Covenants. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other
remedies available to the Buyer pursuant to this Agreement, it will be considered an event of default under the Note.

 

5.
Governing Law; Miscellaneous.

 

a.
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without
regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state and county
of New York. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The
Company and Buyer waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s
fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

    	9 

    	 

    

 

b.
Counterparts; Signatures by Facsimile. This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts
have been signed by each party and delivered to the other party. This Agreement, once executed by a party, may be delivered to
the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering
this Agreement.

 

c.
Headings. The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the
interpretation of, this Agreement.

 

d.
Severability. In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute
or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed
modified to conform with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any
law shall not affect the validity or enforceability of any other provision hereof.

 

e.
Entire Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of
the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither
the Company nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision
of this Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f.
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder
shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered
or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid,
(iv) via electronic mail or (v) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such
other address as such party shall have specified most recently by written notice. Any notice or other communication required or
permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation
generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during
normal business hours where such notice is to be received) or delivery via electronic mail, or the first business day following
such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or
(b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address,
or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

 

    	10 

    	 

    

 

If
to the Company, to:

Endonovo
Therapeutics, Inc.

6320
Canoga Avenue,15th Floor

Woodland
Hills, CA 91367

Attn:
Alan Collier, CEO

 

If
to the Buyer:

EAGLE
EQUITIES, LLC

91
Shelton Ave, Suite 107,

New
Haven, CT 06511

Attn:
Yakov Borenstein, Manager

 

Each
party shall provide notice to the other party of any change in address.

 

g.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the
prior written consent of the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any “qualified
person”, any “permitted assigns”, or “prospective transferee” that acquires or purchases Note Securities
in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act,
without the consent of the Company with Buyer’s Opinion of Counsel. A qualified person is an “accredited investor”
transferee, assignee, or purchaser of the Note who succeeds to the Holder’s right, title and interest to all or a portion
of the Note accompanied with an Opinion of Counsel as provided for in Section 2(f).

 

h.
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

i.
Survival. The representations and warranties of the Company and the agreements and covenants set forth in this Agreement
shall survive the closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The
Company agrees to indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage
arising as a result of or related to any breach or alleged breach by the Company of any of its representations, warranties and
covenants set forth in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses
as they are incurred.

 

j.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably
request in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions
contemplated hereby.

 

k.
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

l.
Remedies. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the
Buyer by vitiating the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the
remedy at law for a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or
threatened breach by the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other
available remedies at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining,
preventing or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity
of showing economic loss and without any bond or other security being required.

 

 

IN
WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above
written.

 

Endonovo
Therapeutics, Inc.

 

	By:	 	 
	Name:	Alan
    Collier	 
	Title:	CEO	 

 

EAGLE
EQUITIES, LLC.

 

	By:
    	 	 
	Name:	Yakov
    Borenstein	 
	Title:	Manager	 

 

AGGREGATE
SUBSCRIPTION AMOUNT: $2,120,000

 

Aggregate
Principal Amount of Notes:

 

Aggregate
Purchase Price:

 

Note
1: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Back
End Note 1: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Note
2: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Back
End Note 2: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Note
3: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Back
End Note 3: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Note
4: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Back
End Note 4: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Note
5: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

Back
End Note 5: $210,000.00, less $12,000.00 in OID, less $5,000 in legal fees.

 

    	11 

    	 

    

 

EXHIBIT
A

 

NOTE
1 - $210,000.00

 

    	12 

    	 

    

 

EXHIBIT
B

BACK
END NOTE 1- $210,000.00

 

    	13 

    	 

    

 

EXHIBIT
C

NOTE
2 - $210,000.00

 

    	14 

    	 

    

 

EXHIBIT
D

BACK
END NOTE 2- $210,000.00

 

    	15 

    	 

    

 

EXHIBIT
E

NOTE
3 - $210,000.00

 

    	16 

    	 

    

 

EXHIBIT
F

BACK
END NOTE 3- $210,000.00

 

    	17 

    	 

    

 

EXHIBIT
G

NOTE
4 - $210,000.00

 

    	18 

    	 

    

 

EXHIBIT
H

BACK
END NOTE 4- $210,000.00

 

    	19 

    	 

    

 

EXHIBIT
I

NOTE
5 - $210,000.00

 

    	20 

    	 

    

 

EXHIBIT
J

BACK
END NOTE 5- $210,000.00

 

    	21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00269-of-00352.parquet"}]]